CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)

被引：0
|
作者：
Leschenko, Y. [1 ]
Chebotareva, T. [1 ]
Spizhenko, N. [1 ]
Fedusenko, A. [1 ]
Sharaevskiy, O. [1 ]
Buryk, V. [1 ]
机构：
[1] Cyber Knife, Cyber Clin Spizhenko, Kapitanivka, Kyiv Region, Ukraine
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1155
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [2] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [3] Feasibility of Stereotactic Ablative Radiotherapy (SABR) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
    Woodford, Katrina
    Panettieri, Vanessa
    Trieumy Tran Le
    Senthi, Sashendra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1467 - S1468
  • [4] Is stereotactic ablative radiotherapy (SABR) a safe treatment for multiple primary lung cancer (MPLC) non-small cell lung cancer (NSCLC)?
    Murray, P. F.
    Spencer, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    Clarke, K.
    Franks, K.
    LUNG CANCER, 2016, 91 : S48 - S48
  • [5] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [6] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
    Mak, Ka-Man
    McDonald, Fiona
    Teague, Jonathan
    Faivre-Finn, Corinne
    Forster, Martin
    Hanna, Gerard
    Moinuddin, Syed
    Conibear, John
    Harden, Susan
    Popat, Sanjay
    Califano, Raffaele
    Farrelly, Laura
    Counsell, Nicholas
    Saron, T. M. G.
    LUNG CANCER, 2022, 165 : S71 - S71
  • [7] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
  • [8] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [9] STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) OUTCOMES FOR PRIMARY AND METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PULMONARY TUMOURS
    Thibault, Isabelle
    Poon, Ian
    Erler, Darby
    Kim, Anthony
    Keller, Brian
    Yeung, Latifa
    Jain, Suneil
    Soliman, Hany
    Lochray, Fiona
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S837 - S838
  • [10] Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)
    Pickles, R. L.
    Iqbal, S.
    Atherton, P.
    Turnbull, H.
    Mcmenemin, R.
    Walker, C.
    Pilling, K.
    Muller, M.
    Mott, J.
    Mccallum, H.
    LUNG CANCER, 2016, 91 : S47 - S48
12345